NCTC
GILD icon

New Covenant Trust Company’s Gilead Sciences GILD Stock Holding History

New Covenant Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$253K Buy
+1,697
New +$238K 0.18% 102
2024
Q2 		– Sell
-844
Closed -$61.8K – 216
2024
Q1 		$61.8K Buy
+844
New +$64.9K 0.06% 159

Other funds holding GILD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return

New Covenant Trust Company's GILD Position: Q3 2026 in Review

New Covenant Trust Company opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,697 shares worth $253K. The stake represents 0.18% of the portfolio and ranks #102 among its holdings. This is a return to the name: New Covenant Trust Company previously reported a position in GILD as recently as Q1 2024.

New Covenant Trust Company first reported a position in GILD in Q1 2024 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • New Covenant Trust Company held 1,697 shares of Gilead Sciences worth $253K as of Q3 2026.
  • Gilead Sciences was a new New Covenant Trust Company position in Q3 2026.
  • Gilead Sciences made up 0.18% of New Covenant Trust Company's portfolio in Q3 2026, its #102 holding.
  • New Covenant Trust Company first reported a position in Gilead Sciences in Q1 2024 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on New Covenant Trust Company's 13F filing for Q3 2026, filed 8 Oct 2026.